Clinical trials

  • LAD106 for Inflammatory diseases
  • GB-0895 for Severe uncontrolled asthma | Asthma
  • ZANUBRUTINIB for Peripheral anti-MAG neuropathy|Waldenström macroglobulinemia|Marginal zone lymphoma|Chronic lymphocytic leukemia|Monoclonal gammopathy of undetermined significance
  • OBINUTUZUMAB for Idiopathic nephrotic syndrome
  • Brimonidine tartrate for Myopia
  • Clinical trial in Advanced solid tumors
  • NNC1679-0001 for Type 2 diabetes
  • AX-0810 for Cholestatic liver disease
  • TLN-372 for KRAS-mutant advanced or metastatic solid tumors
  • BAY 3620122 for Vasodilatory shock
  • Clinical trial in Advanced metastatic pancreatic adenocarcinoma
  • RILVEGOSTOMIG for Biliary tract cancer | Cholangiocarcinoma | Gallbladder carcinoma